1,2-Dichloroethane → HCID 178458179, compound
Reaction equation
[CH3:1][N:2]1[C:6]2[CH:7]=[C:8]([O:11][CH2:12][CH2:13][CH3:14])[CH:9]=[CH:10][C:5]=2[N:4]([CH2:15][C:16]2[CH:24]=[CH:23][C:19]([C:20](O)=[O:21])=[CH:18][CH:17]=2)[C:3]1=[N:25][C:26]1[CH:31]=[CH:30][C:29]([C:32]2[CH:36]=[CH:35][S:34][CH:33]=2)=[CH:28][CH:27]=1.O.[NH:38]1[C:42]([NH2:43])=[N:41][N:40]=[N:39]1.C1C=CC2N(O)N=NC=2C=1.C(Cl)CCl.CCN(C(C)C)C(C)C>CN(C=O)C>[CH3:1][N:2]1[C:6]2[CH:7]=[C:8]([O:11][CH2:12][CH2:13][CH3:14])[CH:9]=[CH:10][C:5]=2[N:4]([CH2:15][C:16]2[CH:17]=[CH:18][C:19]([C:20]([NH:43][C:42]3[NH:41][N:40]=[N:39][N:38]=3)=[O:21])=[CH:23][CH:24]=2)[C:3]1=[N:25][C:26]1[CH:27]=[CH:28][C:29]([C:32]2[CH:36]=[CH:35][S:34][CH:33]=2)=[CH:30][CH:31]=1Participants
Conditions
- Temperature
- 40 °C
Procedure
To the title compound of Example 18, Step G (0.18 mmol, 88 mg) was added a solution of 1H-tetraazol-5-amine monohydrate (0.72 mmol, 74 mg), HOBt (0.72 mmol, 110 mg), EDC (0.72 mmol, 138 mg) and DIEA (1.08 mmol, 300 μL) in DMF (4 mL). The reaction mixture was stirred at 40° C. overnight, then concentrated under reduced pressure. The residue was taken up in 4:1 dioxane/H2O, acidified with TFA, and purified by reverse-phase chromatography (20-80% MeCN in H2O, both containing 0.1% TFA). Lyophilization afforded the title compound as a white solid. H1 NMR (500 MHz, d6-DMSO): 8.06 (d, J=6.7 Hz, 2H), 7.88 (m, 1H), 7.75 (d, J=8.5 Hz, 2H), 7.65 (dd, J=3.0, 5.0 Hz, 1H), 7.57 (d, J=4.4 Hz, 1H), 7.50-7.45 (m, 2H), 7.38 (d, J=8.7 Hz, 2H), 7.26 (d, J=8.0 Hz, 1H), 7.05 (m, 1H), 5.55 (s, 2H), 4.04 (t, J=6.6 Hz, 2H), 3.58 (s, 1H), 3.43 (s, 3H), 3.19 (m, 2H), 1.78 (m, 2H), 1.01 (t, J=7.4 Hz, 3H). LC-MS (ESI, Method B): 1.79 min, m/z 565.0 (M+1).
Workup
- concentrationconcentrated under reduced pressure
- custompurified by reverse-phase chromatography (20-80% MeCN in H2O
Sources & evidence
- ORD record
- ord-804eb0b4e66f4c14a08bcfb2705e0c63
- Source dataset
- uspto-grants-2007_11
- Patent number
- US07301036B2
Reaction notes
Loading…